These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11985951)

  • 21. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented Insulin and Leptin Resistance of High Fat Diet-Fed APPswe/PS1dE9 Transgenic Mice Exacerbate Obesity and Glycemic Dysregulation.
    Lee YH; Hsu HC; Kao PC; Shiao YJ; Yeh SH; Shie FS; Hsu SM; Yeh CW; Liu HK; Yang SB; Tsay HJ
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolic syndrome: a tug-of-war with no winner.
    Brotman DJ; Girod JP
    Cleve Clin J Med; 2002 Dec; 69(12):990-4. PubMed ID: 12546272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Metabolic Syndrome Puzzles; Possible Pathogenesis and Management.
    Marzoog BA
    Curr Diabetes Rev; 2023; 19(4):e290422204258. PubMed ID: 35507784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dysmetabolic syndrome: epidemiology and etiology.
    Sauerwein HP
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inflammation and diabetes].
    Löbner K; Füchtenbusch M
    MMW Fortschr Med; 2004 Sep; 146(35-36):32-3, 35-6. PubMed ID: 15540536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity.
    Kim OK; Jun W; Lee J
    Ann Nutr Metab; 2015; 67(4):218-27. PubMed ID: 26452040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could omega-3 fatty acids a therapeutic treatment of the immune-metabolic consequence of intermittent hypoxia in obstructive sleep apnea?
    Alzoubi MR; Aldomi Al-Domi H
    Diabetes Metab Syndr; 2017; 11(4):297-304. PubMed ID: 27389079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of inflammation in obesity-linked insulin resistance.
    Marette A
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S46-8. PubMed ID: 14704744
    [No Abstract]   [Full Text] [Related]  

  • 32. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542
    [No Abstract]   [Full Text] [Related]  

  • 33. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.
    Ferrante AW
    J Intern Med; 2007 Oct; 262(4):408-14. PubMed ID: 17875176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obesity and inflammation].
    Recasens M; Ricart W; Fernández-Real JM
    Rev Med Univ Navarra; 2004; 48(2):49-54. PubMed ID: 15382613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metabolic and hormonal links in obese individuals with and without symptoms of syndrome X].
    Nedĕlníková K; Svacina S; Matoulek M; Sonka J
    Sb Lek; 2000; 101(1):67-9. PubMed ID: 10953633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic syndrome.
    Fernandez ML
    Nutr Rev; 2007 Jun; 65(6 Pt 2):S30-4. PubMed ID: 17605311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired insulin clearance as a cause rather than a consequence of insulin resistance.
    Watada H; Tamura Y
    J Diabetes Investig; 2017 Nov; 8(6):723-725. PubMed ID: 28752566
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathophysiology of the metabolic syndrome.
    McCracken E; Monaghan M; Sreenivasan S
    Clin Dermatol; 2018; 36(1):14-20. PubMed ID: 29241747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.